VitaStem VITASTEM in Synthswap SYNTH tauschen

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

What is the project about? First fully audited and native DEX on Base. We will also offer V3 and V4 tech alongside other DeFi products What makes your project unique? Synthswap is one of the first decentralized exchanges (DEX) with an automated market-maker (AMM) in the Base ecosystem. Compared to its competitors, Synthswap will enable trading with the lowest fees! Rewards from Staking and Yield Farming will be among the most lucrative. History of your project. Launched today What’s next for your project? Bring more features like V3, V4, more token utility and grow the dexes volume and userbase What can your token be used for? Stake for real yield (platform fee sharing), Governance, Launchpad allocation.